Literature DB >> 15098630

Clinical applications of positron emission tomography in cardiology: a review.

F Y J Keng1.   

Abstract

Myocardial viability assessment is of utmost importance in the assessment of patients with poor left ventricular function undergoing revascularisation therapies or cardiac transplantation. Cardiac positron emission tomography (PET) is widely regarded as a "gold" standard in myocardial viability assessment. We review the current data on this subject with respect to tracers and techniques, and prognostic information. The newer cardiac PET techniques in perfusion, hypoxia and neuronal imaging are also discussed, with mention of possible new applications of cardiac PET.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15098630

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  4 in total

Review 1.  Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease.

Authors:  Thaddeus J Wadas; Edward H Wong; Gary R Weisman; Carolyn J Anderson
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 2.  The development of copper radiopharmaceuticals for imaging and therapy.

Authors:  Monica Shokeen; Thaddeus J Wadas
Journal:  Med Chem       Date:  2011-09       Impact factor: 2.745

3.  Evaluation of (4-[18F]Fluorophenyl)triphenylphosphonium ion. A potential myocardial blood flow agent for PET.

Authors:  Timothy M Shoup; David R Elmaleh; Anna-Liisa Brownell; Aijun Zhu; J Luis Guerrero; Alan J Fischman
Journal:  Mol Imaging Biol       Date:  2011-06       Impact factor: 3.488

4.  Cross-validation study between the HRRT and the PET component of the SIGNA PET/MRI system with focus on neuroimaging.

Authors:  Julia G Mannheim; Ju-Chieh Kevin Cheng; Nasim Vafai; Elham Shahinfard; Carolyn English; Jessamyn McKenzie; Jing Zhang; Laura Barlow; Vesna Sossi
Journal:  EJNMMI Phys       Date:  2021-02-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.